全文获取类型
收费全文 | 7777篇 |
免费 | 526篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 197篇 |
妇产科学 | 283篇 |
基础医学 | 1275篇 |
口腔科学 | 184篇 |
临床医学 | 682篇 |
内科学 | 1481篇 |
皮肤病学 | 161篇 |
神经病学 | 843篇 |
特种医学 | 313篇 |
外国民族医学 | 1篇 |
外科学 | 987篇 |
综合类 | 44篇 |
一般理论 | 4篇 |
预防医学 | 496篇 |
眼科学 | 87篇 |
药学 | 598篇 |
中国医学 | 3篇 |
肿瘤学 | 640篇 |
出版年
2023年 | 49篇 |
2022年 | 47篇 |
2021年 | 132篇 |
2020年 | 108篇 |
2019年 | 151篇 |
2018年 | 147篇 |
2017年 | 119篇 |
2016年 | 165篇 |
2015年 | 199篇 |
2014年 | 249篇 |
2013年 | 266篇 |
2012年 | 482篇 |
2011年 | 519篇 |
2010年 | 304篇 |
2009年 | 272篇 |
2008年 | 444篇 |
2007年 | 456篇 |
2006年 | 417篇 |
2005年 | 432篇 |
2004年 | 450篇 |
2003年 | 400篇 |
2002年 | 353篇 |
2001年 | 162篇 |
2000年 | 158篇 |
1999年 | 144篇 |
1998年 | 89篇 |
1997年 | 74篇 |
1996年 | 68篇 |
1995年 | 67篇 |
1994年 | 57篇 |
1993年 | 53篇 |
1992年 | 105篇 |
1991年 | 88篇 |
1990年 | 86篇 |
1989年 | 87篇 |
1988年 | 85篇 |
1987年 | 70篇 |
1986年 | 68篇 |
1985年 | 82篇 |
1984年 | 36篇 |
1983年 | 33篇 |
1979年 | 34篇 |
1978年 | 33篇 |
1977年 | 32篇 |
1975年 | 30篇 |
1973年 | 46篇 |
1972年 | 28篇 |
1971年 | 29篇 |
1970年 | 28篇 |
1966年 | 28篇 |
排序方式: 共有8322条查询结果,搜索用时 15 毫秒
1.
2.
We have shown previously that the plant cannabinoid cannabidiol (CBD) elevates intracellular calcium levels in both cultured hippocampal neurones and glia. Here, we investigated whether the main psychotropic constituent of cannabis, Δ9-tetrahydrocannabinol (THC) alone or in combination with other cannabis constituents can cause similar responses, and whether THC affects the responses induced by CBD. Our experiments were performed with 1 μM pure THC (pTHC), with 1 μM pure CBD (pCBD), with a high-THC, low CBD cannabis extract (eTHC), with a high-CBD, low THC cannabis extract (eCBD), with a mixture of eTHC and eCBD (THC:CBD = 1:1) or with corresponding ‘mock extracts’ that contained only pTHC and pCBD mixed in the same proportion as in eTHC, eCBD or the 1:1 mixture of eTHC and eCBD. 相似文献
3.
Prof. Dr. Alexander Kapp Prof. Dr. Bettina Wedi 《Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete》2006,57(10):854-854
Ohne Zusammenfassung 相似文献
4.
The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology 总被引:6,自引:0,他引:6
In order to test its potential application to surgical neuropathology, the monoclonal antibody Ki-67 was used to demonstrate immunohistochemically the proliferating cells in 40 neoplasms of the nervous system. The antibody, which reacts with a nuclear protein expressed in the G1, G2, S, and M phases of the cell cycle, was demonstrated in frozen sections of all lesions. The highest incidence of stained nuclei was found in a metastatic carcinoma (57%). The percentage of stained cells in gliomas was in general agreement with the histologic grade and known biologic behavior of the lesions, ranging from 0.6% in a pilocytic astrocytoma to 12.4% in a glioblastoma multiforme. In the fibrillary astrocytic neoplasms of low cellularity, there were good correlations between the percentages of stained cells and the degrees of nuclear pleomorphism and chromatin density. In meningiomas, schwannomas, and a cerebellar hemangioblastoma, the fractions of labeled nuclei were less than 1%. The percentage of stained cells in pituitary adenomas showed considerable variation among the four cases (0.2-1.5%), the biologic significance of which is unknown. In four of the above cases, Ki-67 staining was performed on air-dried squash preparations with excellent visualization of immunoreactive nuclei. In one case, a hemangioblastoma, no stained nuclei were seen. The results confirm that Ki-67 staining is technically suitable as a diagnostic method, with good correlations between frozen sections and smear preparations. Determination of the replicating cell fraction could become an important additional criterion to predict the biologic behavior of nervous system neoplasms. 相似文献
5.
6.
7.
8.
Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy) 下载免费PDF全文
Rufinamide, a triazole derivative that is structurally distinct from currently marketed antiepileptic drugs (AEDs), is in development for the adjunctive treatment of Lennox-Gastaut syndrome (LGS) in children and adults. Rufinamide is well absorbed after oral administration, demonstrates low protein binding, and is metabolized by enzymatic hydrolysis without involvement of cytochrome P450 enzymes, conferring a low drug interaction potential. In a randomized, double-blind trial involving 138 adult and pediatric patients with LGS, compared with placebo, rufinamide 45 mg/kg/day resulted in significantly superior reductions in drop attacks (median change −42.5% vs +1.4% with placebo) and total seizures (−32.1% vs −11.7% with placebo), accompanied by significantly higher responder rates. These results are comparable with findings reported for other AEDs in randomized, controlled clinical trials in patients with LGS. Rufinamide produced statistically significant seizure reduction which was maintained during long-term therapy and accompanied by good tolerability. The most frequently reported adverse events from a pooled safety database evaluating short- and long-term therapy were headache (22.9% and 29.5%), dizziness (15.5% and 22.5%) and fatigue (13.6% and 17.7%). Rufinamide therefore presents a favorable efficacy and tolerability profile and is a promising candidate for the adjunctive therapy of LGS. 相似文献
9.
Klaus Rauber Kathrin S. Heidinger Bettina Kemkes-Matthes 《Cardiovascular and interventional radiology》1997,20(3):169-173
Purpose To determine the systemic effects of local fibrinolytic therapy with low-dose recombinant tissue-type plasminogen activator
(rt-PA).
Methods Ten patients received intrathrombal infusion of 20 mg rt-PA and heparin for local thrombolysis and had subsequent percutaneous
transluminal angioplasty (PTA). Eight controls underwent PTA and received heparin alone. We measured t-PA, D-Dimer, and fibrinogen
levels before, directly after, and 20, 40, and 60 min and 24 hr after therapy.
Results In the thrombolysis group the t-PA level peaked immediately after infusion and then declined within 1 hr. D-Dimer increased
and remained elevated, whereas in the control group only t-PA levels increased, and only after 24 hr. Fibrinogen remained
within the normal range in both groups. Eight of ten patients in the thrombolysis group and seven of eight with PTA had clinical
improvement after the procedure.
Conclusions The increase in D-Dimer in the rt-PA group indicates a good local fibrinolytic effect. The fact that fibrinogen levels remained
unchanged indicates that there is a lack of systemic fibrinogenolysis. 相似文献
10.